Datavault AI Fires CEO Nathaniel Bradley
Datavault AI ousts CEO Nathaniel Bradley amid scrutiny over a $150M Bitcoin deal restatement and going-concern risks. Get the latest.
Stocks · News reference
DataMEDS AI Secures Commercial Supply Agreement for Six Compounded Peptides
DataMEDS AI has entered into a commercial supply agreement to provide six compounded peptides, leveraging its distribution infrastructure and the Corexa Health pharmacy network.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Meds Apotek AB Releases Q3 2026 Interim Report
Meds Apotek AB has published its interim report for the third quarter of 2026, highlighting operational updates including the status of its logistics center in Eskilstuna.
DataMEDS AI Signs MOU to Deploy Health Lives Here GLP-1 Patient Management Program with Florida-Based HMO
DataMEDS AI has signed a non-binding memorandum of understanding (MOU) to deploy its 'Health Lives Here' GLP-1 patient management program with a Florida-based HMO.
DataMEDS AI Terminates Second Amended and Restated Letter of Intent with Datavault AI and Other Parties
DataMEDS AI has terminated a previously announced letter of intent for the acquisition of intellectual property due to market conditions.
8-K filing — DataMeds AI, Inc. (MEDS)
Filed: 2026-11-05 AccNo: 0001493152-26-050033 Size: 223 KB Item 1.02: Termination of a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Datavault AI Signs Non-Binding Letter of Intent to Acquire 19.9% Equity Stake in DataMEDS AI
Datavault AI has announced a non-binding letter of intent to acquire a 19.9% equity stake in DataMEDS AI, Inc. in exchange for an expanded technology license.